Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2004
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Antifibrinolytic Agents (MeSH)
- Aspirin (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clopidogrel (MeSH)
- Coronary Artery Bypass (MeSH)
- Cost-Benefit Analysis (MeSH)
- Drug Costs (MeSH)
- Humans (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Ticlopidine (MeSH)
published in
- Canadian Journal of Cardiology Journal